 |
 |

Mechanisms of Morbid Hearing Loss Associated With Tumors of the Endolymphatic Sac in von Hippel-Lindau Disease
John A. Butman, MD, PhD;
H. Jeffrey Kim, MD;
Martin Baggenstos, MD;
Joshua M. Ammerman, MD;
James Dambrosia, PhD;
Athos Patsalides, MD;
Nicholas J. Patronas, MD;
Edward H. Oldfield, MD;
Russell R. Lonser, MD
JAMA. 2007;298:41-48.
Context Endolymphatic sac tumors (ELSTs) are associated with von Hippel-Lindau disease and cause irreversible sensorineural hearing loss (SNHL) and vestibulopathy. The underlying mechanisms of audiovestibular morbidity remain unclear and optimal timing of treatment is not known.
Objective To define the mechanisms underlying audiovestibular pathophysiology associated with ELSTs.
Design, Setting, and Patients Prospective and serial evaluation of patients with von Hippel-Lindau disease and ELSTs at the National Institutes of Health between May 1990 and December 2006.
Main Outcome Measures Clinical findings and audiologic data were correlated with serial magnetic resonance imaging and computed tomography imaging studies to determine mechanisms underlying audiovestibular dysfunction.
Results Thirty-five patients with von Hippel-Lindau disease and ELSTs in 38 ears (3 bilateral ELSTs) were identified. Tumor invasion of the otic capsule was associated with larger tumors (P = .01) and occurred in 7 ears (18%) causing SNHL (100%). No evidence of otic capsule invasion was present in the remaining 31 ears (82%). SNHL developed in 27 of these 31 ears (87%) either suddenly (14 ears; 52%) or gradually (13 ears; 48%) and 4 ears had normal hearing. Intralabyrinthine hemorrhage was found in 11 of 14 ears with sudden SNHL (79%; P < .001) but occurred in none of the 17 ears with gradual SNHL or normal hearing. Tumor size was not related to SNHL (P = .23) or vestibulopathy (P = .83).
Conclusions ELST-associated SNHL and vestibulopathy may occur suddenly due to tumor-associated intralabyrinthine hemorrhage, or insidiously, consistent with endolymphatic hydrops. Both of these pathophysiologic mechanisms occur with small tumors that are not associated with otic capsule invasion.
Author Affiliations: Diagnostic Radiology Department, The Clinical Center of the National Institutes of Health (Drs Butman, Patsalides, and Patronas); Neuro-Otology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health (Dr Kim); Surgical Neurology Branch (Drs Baggenstos, Ammerman, Oldfield, and Lonser), Biostatistics Branch (Dr Dambrosia), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
RELATED ARTICLES
Endolymphatic Sac Tumors in von Hippel-Lindau Disease
Arch Otolaryngol Head Neck Surg. ;133():857-857.
FULL TEXT
Adult Hearing Loss
, , and
JAMA. ;298():130-130.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Neurologic Manifestations of von Hippel-Lindau Disease
Butman et al.
JAMA 2008;300:1334-1342.
ABSTRACT
| FULL TEXT
Kidney Diseases: Environmental and Genetic Factors
Grunfeld
CJASN 2008;3:654-657.
FULL TEXT
|